{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T04:18:27Z","timestamp":1780460307263,"version":"3.54.1"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Gerontology and Geriatrics"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.archger.2020.104013","type":"journal-article","created":{"date-parts":[[2020,1,20]],"date-time":"2020-01-20T11:29:58Z","timestamp":1579519798000},"page":"104013","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Cognitive and metabolic outcomes of vildagliptin addition to the therapy in patients with type 2 diabetes mellitus: 26 week follow-up study"],"prefix":"10.1016","volume":"88","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1124-9720","authenticated-orcid":false,"given":"Esra","family":"Ates Bulut","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7380-4603","authenticated-orcid":false,"given":"Zehra Yagmur","family":"Sahin Alak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7079-9696","authenticated-orcid":false,"given":"Ozge","family":"Dokuzlar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suleyman Emre","family":"Kocyigit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6042-1718","authenticated-orcid":false,"given":"Pinar","family":"Soysal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmet Turan","family":"Isik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.archger.2020.104013_bib0005","first-page":"S13","article-title":"Standards of medical care in Diabetes-2019","volume":"42","author":"2. Classification and Diagnosis of Diabetes Standards of Medical Care in Diabetes-2019","year":"2019","journal-title":"Diabetes Care"},{"issue":"8","key":"10.1016\/j.archger.2020.104013_bib0010","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1097\/JGP.0b013e31823038db","article-title":"Psychiatric disorders presenting in the elderly with type 2 diabetes mellitus","volume":"20","author":"Alagiakrishnan","year":"2012","journal-title":"The American Journal of Geriatric Psychiatry: Official Journal of the American Association for Geriatric Psychiatry"},{"key":"10.1016\/j.archger.2020.104013_bib0015","series-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"2013"},{"issue":"12","key":"10.1016\/j.archger.2020.104013_bib0020","doi-asserted-by":"crossref","first-page":"255","DOI":"10.21037\/atm.2018.04.41","article-title":"DPP-4 inhibitors: A promising therapeutic approach against Alzheimer\u2019s disease","volume":"6","author":"Angelopoulou","year":"2018","journal-title":"Annals of Translational Medicine"},{"issue":"2","key":"10.1016\/j.archger.2020.104013_bib0025","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.diabres.2013.11.010","article-title":"Diabetes in south and Central America: An update","volume":"103","author":"Aschner","year":"2014","journal-title":"Diabetes Research and Clinical Practice"},{"issue":"10","key":"10.1016\/j.archger.2020.104013_bib0030","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/s41574-018-0048-7","article-title":"Cognitive decline and dementia in diabetes mellitus: Mechanisms and clinical implications","volume":"14","author":"Biessels","year":"2018","journal-title":"Nature Reviews Endocrinology"},{"issue":"2","key":"10.1016\/j.archger.2020.104013_bib0035","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S1474-4422(08)70021-8","article-title":"Cognition and diabetes: A lifespan perspective","volume":"7","author":"Biessels","year":"2008","journal-title":"The Lancet Neurology"},{"key":"10.1016\/j.archger.2020.104013_bib0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.archger.2019.06.001","article-title":"Effects of vildagliptin, a DPP-4 inhibitor, in elderly diabetic patients with mild cognitive impairment","volume":"84","author":"Borzi","year":"2019","journal-title":"Archives of Gerontology and Geriatrics"},{"key":"10.1016\/j.archger.2020.104013_bib0045","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3389\/fnagi.2017.00247","article-title":"Strong association between plasma dipeptidyl peptidase-4 activity and impaired cognitive function in elderly population with normal glucose tolerance","volume":"9","author":"Chen","year":"2017","journal-title":"Frontiers in Aging Neuroscience"},{"issue":"3","key":"10.1016\/j.archger.2020.104013_bib0050","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S1474-4422(04)00681-7","article-title":"Insulin and neurodegenerative disease: Shared and specific mechanisms","volume":"3","author":"Craft","year":"2004","journal-title":"The Lancet Neurology"},{"issue":"1","key":"10.1016\/j.archger.2020.104013_bib0055","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1001\/archneurol.2011.233","article-title":"Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: A pilot clinical trial","volume":"69","author":"Craft","year":"2012","journal-title":"Archives of Neurology"},{"key":"10.1016\/j.archger.2020.104013_bib0060","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.neuroscience.2012.10.045","article-title":"The incretin analogue D-Ala2GIP reduces plaque load, astrogliosis and oxidative stress in an APP\/PS1 mouse model of Alzheimer\u2019s disease","volume":"228","author":"Duffy","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.archger.2020.104013_bib0065","doi-asserted-by":"crossref","DOI":"10.14744\/nci.2017.85047","article-title":"Validity and Reliability of Geriatric Depression Scale - 15 (Short Form) in Turkish older adults","author":"Durmaz","year":"2017","journal-title":"Northern Clinics of Istanbul"},{"issue":"4","key":"10.1016\/j.archger.2020.104013_bib0070","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/dom.12432","article-title":"Sitagliptin, a dipeptidyl peptidase-4 inhibitor, improves recognition memory, oxidative stress and hippocampal neurogenesis and upregulates key genes involved in cognitive decline","volume":"17","author":"Gault","year":"2015","journal-title":"Diabetes, Obesity & Metabolism"},{"issue":"25 Suppl 2","key":"10.1016\/j.archger.2020.104013_bib0075","first-page":"S49","article-title":"2013 ACC\/AHA guideline on the assessment of cardiovascular risk: A report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"129","author":"Goff","year":"2014","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.archger.2020.104013_bib0080","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/jdi.12420","article-title":"Potentials of incretin-based therapies in dementia and stroke in type 2 diabetes mellitus","volume":"7","author":"Groeneveld","year":"2016","journal-title":"Journal of Diabetes Investigation"},{"issue":"1","key":"10.1016\/j.archger.2020.104013_bib0085","doi-asserted-by":"crossref","first-page":"T31","DOI":"10.1530\/JOE-13-0221","article-title":"Central effects of GLP-1: New opportunities for treatments of neurodegenerative diseases","volume":"221","author":"Holscher","year":"2014","journal-title":"The Journal of Endocrinology"},{"key":"10.1016\/j.archger.2020.104013_bib0090","doi-asserted-by":"crossref","first-page":"307","DOI":"10.2147\/CIA.S11718","article-title":"Late onset Alzheimer\u2019s disease in older people","volume":"5","author":"Isik","year":"2010","journal-title":"Clinical Interventions in Aging"},{"issue":"6","key":"10.1016\/j.archger.2020.104013_bib0095","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1017\/S1041610209990664","article-title":"Acetylcholinesterase inhibition and insulin resistance in late onset Alzheimer\u2019s disease","volume":"21","author":"Isik","year":"2009","journal-title":"International Psychogeriatrics"},{"issue":"4","key":"10.1016\/j.archger.2020.104013_bib0100","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1017\/S1041610207005406","article-title":"Is there any relation between insulin resistance and cognitive function in the elderly?","volume":"19","author":"Isik","year":"2007","journal-title":"International Psychogeriatrics"},{"key":"10.1016\/j.archger.2020.104013_bib0105","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.diabres.2016.12.010","article-title":"The effects of sitagliptin, a DPP-4 inhibitor, on cognitive functions in elderly diabetic patients with or without Alzheimer\u2019s disease","volume":"123","author":"Isik","year":"2017","journal-title":"Diabetes Research and Clinical Practice"},{"issue":"12","key":"10.1016\/j.archger.2020.104013_bib0110","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1111\/jphp.12148","article-title":"Vildagliptin: an anti-diabetes agent ameliorates cognitive deficits and pathology observed in streptozotocin-induced Alzheimer\u2019s disease","volume":"65","author":"Kosaraju","year":"2013","journal-title":"The Journal of Pharmacy and Pharmacology"},{"issue":"2","key":"10.1016\/j.archger.2020.104013_bib0115","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s00125-006-0537-4","article-title":"Brain-derived neurotrophic factor (BDNF) and type 2 diabetes","volume":"50","author":"Krabbe","year":"2007","journal-title":"Diabetologia"},{"key":"10.1016\/j.archger.2020.104013_bib0120","doi-asserted-by":"crossref","first-page":"549","DOI":"10.2147\/CIA.S74042","article-title":"Link between type 2 diabetes and Alzheimer\u2019s disease: From epidemiology to mechanism and treatment","volume":"10","author":"Li","year":"2015","journal-title":"Clinical Interventions in Aging"},{"issue":"5","key":"10.1016\/j.archger.2020.104013_bib0125","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s11892-014-0487-z","article-title":"Diabetes mellitus and dementia","volume":"14","author":"Ninomiya","year":"2014","journal-title":"Current Diabetes Reports"},{"issue":"9","key":"10.1016\/j.archger.2020.104013_bib0130","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1212\/WNL.53.9.1937","article-title":"Diabetes mellitus and the risk of dementia: The Rotterdam Study","volume":"53","author":"Ott","year":"1999","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.archger.2020.104013_bib0135","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.numecd.2010.02.022","article-title":"Risk for cardiovascular events in an Italian population of patients with type 2 diabetes","volume":"21","author":"Pellegrini","year":"2011","journal-title":"Nutrition, Metabolism, and Cardiovascular Diseases: NMCD"},{"issue":"1","key":"10.1016\/j.archger.2020.104013_bib0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/JOE-12-0521","article-title":"DPP-4 inhibitors improve cognition and brain mitochondrial function of insulin-resistant rats","volume":"218","author":"Pintana","year":"2013","journal-title":"The Journal of Endocrinology"},{"issue":"5","key":"10.1016\/j.archger.2020.104013_bib0145","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1111\/ejn.12088","article-title":"DPP4-inhibitor improves neuronal insulin receptor function, brain mitochondrial function and cognitive function in rats with insulin resistance induced by high-fat diet consumption","volume":"37","author":"Pipatpiboon","year":"2013","journal-title":"The European Journal of Neuroscience"},{"issue":"13\u201314","key":"10.1016\/j.archger.2020.104013_bib0150","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.lfs.2011.02.003","article-title":"Effects of high-fat diet on insulin receptor function in rat hippocampus and the level of neuronal corticosterone","volume":"88","author":"Pratchayasakul","year":"2011","journal-title":"Life Sciences"},{"issue":"6","key":"10.1016\/j.archger.2020.104013_bib0155","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1212\/01.WNL.0000265401.62434.36","article-title":"Intranasal insulin improves cognition and modulates beta-amyloid in early AD","volume":"70","author":"Reger","year":"2008","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.archger.2020.104013_bib0160","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1093\/gerona\/glu032","article-title":"Dipeptidyl peptidase-4 inhibitors have protective effect on cognitive impairment in aged diabetic patients with mild cognitive impairment","volume":"69","author":"Rizzo","year":"2014","journal-title":"The Journals of Gerontology Series A, Biological Sciences and Medical Sciences"},{"key":"10.1016\/j.archger.2020.104013_bib0165","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3389\/fendo.2014.00110","article-title":"Insulin as a bridge between type 2 diabetes and alzheimer disease - how anti-diabetics could be a solution for dementia","volume":"5","author":"Sebasti\u00e3o","year":"2014","journal-title":"Frontiers in Endocrinology"},{"issue":"1","key":"10.1016\/j.archger.2020.104013_bib0170","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12974-016-0774-5","article-title":"Cerebral ischemic damage in diabetes: An inflammatory perspective","volume":"14","author":"Shukla","year":"2017","journal-title":"Journal of Neuroinflammation"},{"issue":"1","key":"10.1016\/j.archger.2020.104013_bib0175","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0031-9384(04)00348-8","article-title":"Insulin and the CNS: Effects on food intake, memory, and endocrine parameters and the role of intranasal insulin administration in humans","volume":"83","author":"Stockhorst","year":"2004","journal-title":"Physiology & Behavior"},{"issue":"4","key":"10.1016\/j.archger.2020.104013_bib0180","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1172\/JCI59903","article-title":"Demonstrated brain insulin resistance in Alzheimer\u2019s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline","volume":"122","author":"Talbot","year":"2012","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.archger.2020.104013_bib0185","doi-asserted-by":"crossref","first-page":"607","DOI":"10.2147\/CIA.S159966","article-title":"Costs of medication in older patients: Before and after comprehensive geriatric assessment","volume":"13","author":"Unutmaz","year":"2018","journal-title":"Clinical Interventions in Aging"}],"container-title":["Archives of Gerontology and Geriatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167494320300078?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167494320300078?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T20:03:56Z","timestamp":1759089836000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167494320300078"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":37,"alternative-id":["S0167494320300078"],"URL":"https:\/\/doi.org\/10.1016\/j.archger.2020.104013","relation":{},"ISSN":["0167-4943"],"issn-type":[{"value":"0167-4943","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cognitive and metabolic outcomes of vildagliptin addition to the therapy in patients with type 2 diabetes mellitus: 26 week follow-up study","name":"articletitle","label":"Article Title"},{"value":"Archives of Gerontology and Geriatrics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.archger.2020.104013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104013"}}